ADXS — Ayala Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Ayala Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 October 31st	2020 October 31st	2021 October 31st	2022 October 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	32.4	25.2	41.6	25.2	5.21
Net Total Accounts Receivable
Net Total Receivables	0	—	—	—	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	36.1	27.9	43.3	25.8	7.53
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.35	7.23	0.158	0.05	0.642
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	45.3	38.5	46.8	25.9	16.6
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	4.52	3.29	7.88	2.3	25
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	5.73	8.35	7.89	2.3	41
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	39.5	30.2	38.9	23.6	-24.4
Total Liabilities & Shareholders' Equity	45.3	38.5	46.8	25.9	16.6
Total Common Shares Outstanding
Total Preferred Shares Outstanding